These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 8607852
1. Properties of an endothelin-3-sensitive Eta-like endothelin receptor in brain capillary endothelial cells. Vigne P, Desmarets J, Guedin D, Frelin C. Biochem Biophys Res Commun; 1996 Mar 27; 220(3):839-42. PubMed ID: 8607852 [Abstract] [Full Text] [Related]
2. Expression of endothelin receptor subtypes in rabbit saphenous vein. Webb ML, Liu EC, Monshizadegan H, Chao CC, Lynch J, Fisher SM, Rose PM. Mol Pharmacol; 1993 Nov 27; 44(5):959-65. PubMed ID: 8246919 [Abstract] [Full Text] [Related]
3. Identification and characterization of type A endothelin receptors in MMQ cells. Wu-Wong JR, Chiou W, Magnuson SR, Witte DG, Lin CW. Mol Pharmacol; 1993 Aug 27; 44(2):285-91. PubMed ID: 8355666 [Abstract] [Full Text] [Related]
4. Comparison of the contractile effects and binding kinetics of endothelin-1 and sarafotoxin S6b in rat isolated renal artery. Devadason PS, Henry PJ. Br J Pharmacol; 1997 May 27; 121(2):253-63. PubMed ID: 9154335 [Abstract] [Full Text] [Related]
5. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors. Widdowson PS, Kirk CN. Br J Pharmacol; 1996 Aug 27; 118(8):2126-30. PubMed ID: 8864551 [Abstract] [Full Text] [Related]
7. Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites. Simonson MS, Rooney A. Mol Pharmacol; 1994 Jul 27; 46(1):41-50. PubMed ID: 8058055 [Abstract] [Full Text] [Related]
8. Characterization of peptide and nonpeptide antagonists in human kidney. Kuc RE, Karet FE, Davenport AP. J Cardiovasc Pharmacol; 1995 Jul 27; 26 Suppl 3():S373-5. PubMed ID: 8587419 [Abstract] [Full Text] [Related]
9. High affinity interaction of endothelin-3 with recombinant ETA receptors. Desmarets J, Frelin C. Biochem Biophys Res Commun; 1999 Mar 16; 256(2):357-60. PubMed ID: 10079188 [Abstract] [Full Text] [Related]
10. Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in human endothelinA and endothelinB receptors. Masuda Y, Sugo T, Kikuchi T, Kawata A, Satoh M, Fujisawa Y, Itoh Y, Wakimasu M, Ohtaki T. J Pharmacol Exp Ther; 1996 Nov 16; 279(2):675-85. PubMed ID: 8930171 [Abstract] [Full Text] [Related]
11. Nonpeptide endothelin receptor antagonists. VII: Binding characteristics of [3H]SB 209670, a novel nonpeptide antagonist of endothelin receptors. Nambi P, Pullen M, Wu HL, Lee D, Saunders D, Heys R, Aiyar N, Leber J, Elliott J, Brooks D, Ohlstein E, Ruffolo R. J Pharmacol Exp Ther; 1996 Jun 16; 277(3):1567-71. PubMed ID: 8667224 [Abstract] [Full Text] [Related]
12. Functional characterization of endothelin receptors on cultured brain capillary endothelial cells of the rat. Kawai N, Yamamoto T, Yamamoto H, McCarron RM, Spatz M. Neurochem Int; 1997 Oct 16; 31(4):597-605. PubMed ID: 9308010 [Abstract] [Full Text] [Related]
14. Endothelin binding and receptor down regulation in rat glomerular mesangial cells. Baldi E, Dunn MJ. J Pharmacol Exp Ther; 1991 Feb 16; 256(2):581-6. PubMed ID: 1847203 [Abstract] [Full Text] [Related]
16. Endothelin-3 mediated proliferation in wounded human umbilical vein endothelial cells. Wren AD, Hiley CR, Fan TP. Biochem Biophys Res Commun; 1993 Oct 15; 196(1):369-75. PubMed ID: 8216314 [Abstract] [Full Text] [Related]
17. Lack of endothelin ETB receptor binding and function in the rat with a mutant ETB receptor gene. Karaki H, Mitsui-Saito M, Takimoto M, Oda K, Okada T, Ozaki T, Kunieda T. Biochem Biophys Res Commun; 1996 May 06; 222(1):139-43. PubMed ID: 8630059 [Abstract] [Full Text] [Related]
18. Identification of endothelin receptor subtypes in rat ciliary body using subtype-selective ligands. Ripodas A, De Juan JA, Moya FJ, Fernandez-Cruz A, Fernandez-Durango R. Exp Eye Res; 1998 Jan 06; 66(1):69-79. PubMed ID: 9533832 [Abstract] [Full Text] [Related]
19. The endothelin receptor profile in L6 myotubes. Fekete Z, Yang XY, Kimura M, Aviv A. J Pharmacol Exp Ther; 1995 Oct 06; 275(1):215-8. PubMed ID: 7562552 [Abstract] [Full Text] [Related]
20. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist. Nishikibe M, Ohta H, Okada M, Ishikawa K, Hayama T, Fukuroda T, Noguchi K, Saito M, Kanoh T, Ozaki S, Kamei T, Hara K, William D, Kivlighn S, Krause S, Gabel R, Zingaro G, Nolan N, O'Brien J, Clayton F, Lynch J, Pettibone D, Siegl P. J Pharmacol Exp Ther; 1999 Jun 06; 289(3):1262-70. PubMed ID: 10336515 [Abstract] [Full Text] [Related] Page: [Next] [New Search]